PT1173439E - Haloalcoxi imidazonaftiridinas - Google Patents

Haloalcoxi imidazonaftiridinas

Info

Publication number
PT1173439E
PT1173439E PT00918882T PT00918882T PT1173439E PT 1173439 E PT1173439 E PT 1173439E PT 00918882 T PT00918882 T PT 00918882T PT 00918882 T PT00918882 T PT 00918882T PT 1173439 E PT1173439 E PT 1173439E
Authority
PT
Portugal
Prior art keywords
imidazonehtiridines
haloalcoxi
compounds
useful
preventing
Prior art date
Application number
PT00918882T
Other languages
English (en)
Portuguese (pt)
Inventor
Jorg Senn-Bilfinger
Gerhard Grundler
Stefan Postius
Wolfgang-Alexander Simon
Wolfgang Kromer
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of PT1173439E publication Critical patent/PT1173439E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Electroluminescent Light Sources (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
PT00918882T 1999-04-17 2000-04-14 Haloalcoxi imidazonaftiridinas PT1173439E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99107688 1999-04-17

Publications (1)

Publication Number Publication Date
PT1173439E true PT1173439E (pt) 2003-10-31

Family

ID=8237986

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00918882T PT1173439E (pt) 1999-04-17 2000-04-14 Haloalcoxi imidazonaftiridinas

Country Status (12)

Country Link
US (1) US6503923B1 (https=)
EP (1) EP1173439B1 (https=)
JP (1) JP2002542248A (https=)
AT (1) ATE240956T1 (https=)
AU (1) AU3966600A (https=)
CA (1) CA2370231A1 (https=)
DE (1) DE60002855T2 (https=)
DK (1) DK1173439T3 (https=)
ES (1) ES2199810T3 (https=)
PT (1) PT1173439E (https=)
SI (1) SI1173439T1 (https=)
WO (1) WO2000063211A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA008151B1 (ru) * 2000-10-25 2007-04-27 Алтана Фарма Аг Полизамещенные имидазопиридины в качестве ингибиторов желудочной секреции
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
MXPA03007888A (es) * 2001-03-08 2003-12-04 Astrazeneca Ab Compuestos para tratamiento y prevencion de ulcera gastrica inducida por medicamentos.
HUP0400379A3 (en) 2001-08-02 2007-10-29 Altana Pharma Ag Tricyclic epoxides and their use for the preparation of pharmaceutically active agents
PL368586A1 (en) * 2001-08-03 2005-04-04 Altana Pharma Ag Alkyl-substituted imidazopyridines for the treatment of gastrointestinal disorders
US20040235882A1 (en) * 2001-08-03 2004-11-25 Jorg Senn-Bilfinger Amino-substituted imidazopyridines for the treatment of gastrointestial diseases
US7314935B2 (en) 2002-02-15 2008-01-01 Altana Pharma Ag Tricyclic n-acyl compounds
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
AU2003288071A1 (en) 2002-11-19 2004-06-15 Altana Pharma Ag 8-substituted imidazopyridines
MXPA05008490A (es) * 2003-02-17 2005-10-18 Altana Pharma Ag Combinaciones que contienen imidazopiridinas y su uso en el tratamiento de enfermedades gastrointestinales inflamatorias.
ES2335498T3 (es) 2003-03-10 2010-03-29 Nycomed Gmbh Nuevo proceso para la preparacion de reflumilast.
WO2004105795A1 (en) * 2003-05-27 2004-12-09 Altana Pharma Ag Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility
KR20060099524A (ko) 2003-11-03 2006-09-19 아스트라제네카 아베 무증상 위식도 역류의 치료를 위한 이미다조[1,2-ａ]피리딘유도체
AR046893A1 (es) * 2003-12-16 2005-12-28 Altana Pharma Ag Bencimidazoles triciclicos
WO2005058894A1 (en) 2003-12-19 2005-06-30 Altana Pharma Ag Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives
NZ549011A (en) * 2004-02-17 2009-04-30 Altana Pharma Ag Tricyclic imidazopyridines and intermediates for the synthesis thereof
US7931659B2 (en) * 2004-09-10 2011-04-26 Penumbra, Inc. System and method for treating ischemic stroke
CA2582256A1 (en) * 2004-10-01 2006-04-13 Altana Pharma Ag Substituted tricyclic benzimidazoles
US8663694B2 (en) * 2005-03-16 2014-03-04 Takeda Gmbh Taste masked dosage form containing roflumilast

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468400A (en) 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines
IL108520A (en) * 1993-02-15 1997-09-30 Byk Gulden Lomberg Chem Fab 2, 3, 8-TRISUBSTITUTED IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EP0971922B1 (en) * 1997-03-24 2004-04-28 ALTANA Pharma AG Tetrahydropyrido compounds
US6436953B1 (en) 1998-09-23 2002-08-20 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrahydropyridoethers

Also Published As

Publication number Publication date
JP2002542248A (ja) 2002-12-10
US6503923B1 (en) 2003-01-07
WO2000063211A1 (en) 2000-10-26
EP1173439B1 (en) 2003-05-21
ES2199810T3 (es) 2004-03-01
CA2370231A1 (en) 2000-10-26
DK1173439T3 (da) 2003-09-08
ATE240956T1 (de) 2003-06-15
DE60002855T2 (de) 2004-05-06
AU3966600A (en) 2000-11-02
SI1173439T1 (en) 2003-10-31
EP1173439A1 (en) 2002-01-23
DE60002855D1 (de) 2003-06-26

Similar Documents

Publication Publication Date Title
ATE240956T1 (de) Haloalkoxy-imidazonaphthyridine
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
LU91928I2 (fr) Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®)
ATE527250T1 (de) 2,4,6-trisubstituierten pyrimidinen als phosphotidylinositol (pi) 3-kinase inhibitoren und deren verwendung zur behandlung von krebs
BR9916798A (pt) 4-arilamino, 4-arilóxi e 4-ariltio diarilaminas e seus derivados como inibidores seletivos de mek
NZ516562A (en) Pyrimidine-2,4,6-trione metalloproteinase inhibitors
EE200000033A (et) Uudsed tetrasoolderivaadid
DE60121461D1 (de) Kondensierte pyridoindolderivate
TR200401316T4 (tr) Proliferatif hastalıkları tedavi etmek için yöntemler ve bileşikler
DE60121345D1 (de) Alkylierte imidazopyridinderivate
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
YU55200A (sh) Supstituisani bisindolmaleimidi za inhibiranje ćelijske proliferacije
ATE391715T1 (de) Heterozyklische mutilinester und deren verwendung als bakterizide
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
DK1268472T3 (da) 3-aminopyrazolinhibitorer af cyclinafhængige kinaser
DE60112960D1 (de) Kondensierte pyridoindolderivate
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
BR0012169A (pt) Dihidrobenzodiazepinas e seu uso no tratamento de dislipidemia
MXPA04005129A (es) Uso de diamina de acido piridin-2,4-dicarboxilico y de diaminas de acido pirimidin-4,6-dicarboxilico para la inhibicion selectiva de la colagenasa.
MY135375A (en) Pyrimidine-4,6-dicarboxylic acid diamides for selectively inhibiting collagenases
PT1000046E (pt) Derivados de piperazina activos no trato urinario inferior
TR200103858T2 (tr) Hücre yapışmasının önleyicileri olarak ikame edilmiş purin türevleri
ATE259813T1 (de) Triazolopyrimidinderivate
IS7562A (is) Sýanógúanidínforlyf
DK1244643T3 (da) Tryptaseinhibitorer